Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
May-2017 Volume 39 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2017 Volume 39 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis

  • Authors:
    • Bing‑Yun Li
    • Yan‑Hui Gao
    • Jun‑Rui Pei
    • Yan‑Mei Yang
    • Wei Zhang
    • Dian‑Jun Sun
  • View Affiliations / Copyright

    Affiliations: Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1155-1163
    |
    Published online on: March 22, 2017
       https://doi.org/10.3892/ijmm.2017.2933
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Epidemiological investigations indicate that certain ingredients in tea bricks can antagonize the adverse effects of fluoride. Tea polyphenols (TPs), the most bioactive ingredient in tea bricks, have been demonstrated to be potent bone-supporting agents. ClC‑7 is known to be crucial for osteoclast (OC) bone resorption. Thus, in this study, we investigated the potential protective effects of TPs against fluorosis using a mouse model and explored the underlying mechanisms with particular focus on ClC‑7. A total of 40, healthy, 3‑week‑old male C57BL/6 mice were randomly divided into 4 groups (n=10/group) by weight as follows: distilled water (control group), 100 mg/l fluoridated water (F group), water containing 10 g/l TPs (TP group) and water containing 100 mg/l fluoride and 10 g/l TPs (F + TP group). After 15 weeks, and after the mice were sacrificed, the long bones were removed and bone marrow-derived macrophages were cultured ex vivo in order to perform several experiments. OCs were identified and counted by tartrate‑resistant acid phosphatase (TRAP) staining. The consumption of fluoride resulted in severe fluorosis and in an impaired OC function [impaired bone resorption, and a low mRNA expression of nuclear factor of activated T-cells 1 (NFATc1), ATPase H+ transporting V0 subunit D2 (ATP6v0d2) and osteopetrosis‑associated transmembrane protein 1 (Ostm1)]. In the F + TP group, fluorosis was attenuated and OC function was restored, but not the high bone fluoride content. Compared with the F group, mature OCs in the F + TP group expressed higher mRNA levels of ClC‑7 and Ostm1; the transportation and retaining of Cl‑ was improved, as shown by the fluorescence intensity experiment. On the whole, our findings indicate that TPs mitigate fluorosis in C57BL/6 mice by regulating OC bone resorption. Fluoride inhibits OC resorption by inhibiting ClC‑7 and Ostm1, whereas TPs attenuate this inhibitory effect of fluoride.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

WHO: http://www.who.int/water_sanitation_health/publications/fluoride-in-drinking-water/en/. Accessed Nov 10, 2011.

2 

Wang C, Gao Y, Wang W, Zhao L, Zhang W, Han H, Shi Y, Yu G and Sun D: A national cross-sectional study on effects of fluoride-safe water supply on the prevalence of fluorosis in China. BMJ Open. 2:e0015642012. View Article : Google Scholar : PubMed/NCBI

3 

Sun D and Gao Y: Molecular mechanism of pathogenesis of osteofluorosis: a discussion in the view of bone turnover. Chin J Endemiol. 27:239–241. 2008.

4 

Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT and Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 20:345–357. 1999. View Article : Google Scholar : PubMed/NCBI

5 

Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165–176. 1998. View Article : Google Scholar : PubMed/NCBI

6 

Väänänen HK, Zhao H, Mulari M and Halleen JM: The cell biology of osteoclast function. J Cell Sci. 113:377–381. 2000.PubMed/NCBI

7 

Väänänen HK, Karhukorpi EK, Sundquist K, Wallmark B, Roininen I, Hentunen T, Tuukkanen J and Lakkakorpi P: Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts. J Cell Biol. 111:1305–1311. 1990. View Article : Google Scholar : PubMed/NCBI

8 

Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature. 423:337–342. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Kim K, Lee SH, Ha Kim J, Choi Y and Kim N: NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol. 22:176–185. 2008. View Article : Google Scholar

10 

Baron R, Neff L, Louvard D and Courtoy PJ: Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol. 101:2210–2222. 1985. View Article : Google Scholar : PubMed/NCBI

11 

Blair HC, Teitelbaum SL, Ghiselli R and Gluck S: Osteoclastic bone resorption by a polarized vacuolar proton pump. Science. 245:855–857. 1989. View Article : Google Scholar : PubMed/NCBI

12 

Kornak U, Kasper D, Bösl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G and Jentsch TJ: Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 104:205–215. 2001. View Article : Google Scholar : PubMed/NCBI

13 

Jentsch TJ, Stein V, Weinreich F and Zdebik AA: Molecular structure and physiological function of chloride channels. Physiol Rev. 82:503–568. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Zhao Q, Wei Q, He A, Jia R and Xiao Y: CLC-7: A potential therapeutic target for the treatment of osteoporosis and neurodegeneration. Biochem Biophys Res Commun. 384:277–279. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Leisle L, Ludwig CF, Wagner FA, Jentsch TJ and Stauber T: ClC-7 is a slowly voltage-gated 2Cl(−)/1H(+)-exchanger and requires Ostm1 for transport activity. EMBO J. 30:2140–2152. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Lange PF, Wartosch L, Jentsch TJ and Fuhrmann JC: ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature. 440:220–223. 2006. View Article : Google Scholar : PubMed/NCBI

17 

Sun D, Gao Y, Zhao L, Yu G, Wu L and Li Q: A cross-sectional survey on drinking brick-tea type fluorosis in China. Chin J Endemiol. 27:513–517. 2008.

18 

Sun D, Gao Y, Yu G, Liu Y, Zhao X, Wu L, Li Q and Sun Y: Prevalence characteristics of drink-tea type fluorosis. Chin J Endemiol. 27:121–123. 2008.

19 

Varol E, Icli A, Aksoy F, Bas HA, Sutcu R, Ersoy IH, Varol S and Ozaydin M: Evaluation of total oxidative status and total antioxidant capacity in patients with endemic fluorosis. Toxicol Ind Health. 29:175–180. 2013. View Article : Google Scholar

20 

Wang Q, Cui KP, Xu YY, Gao YL, Zhao J, Li DS, Li XL and Huang HJ: Coal-burning endemic fluorosis is associated with reduced activity in antioxidative enzymes and Cu/Zn-SOD gene expression. Environ Geochem Health. 36:107–115. 2014. View Article : Google Scholar

21 

Cabrera C, Artacho R and Giménez R: Beneficial effects of green tea - a review. J Am Coll Nutr. 25:79–99. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Shen CL, Yeh JK, Cao JJ and Wang JS: Green tea and bone metabolism. Nutr Res. 29:437–456. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Shen CL, Yeh JK, Stoecker BJ, Chyu MC and Wang JS: Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats. Bone. 44:684–690. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Junrui P, Bingyun L, Yanhui G, Xu J, Darko GM and Dianjun S: Relationship between fluoride exposure and osteoclast markers during RANKL-induced osteoclast differentiation. Environ Toxicol Pharmacol. 46:241–245. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Liu XL, Song J, Liu KJ, Wang WP, Xu C, Zhang YZ and Liu Y: Role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro. J Huazhong Univ Sci Technolog Med Sci. 35:712–715. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Dean HT: Fluorine in the control of dental caries. J Am Dent Assoc. 52:1–8. 1956. View Article : Google Scholar : PubMed/NCBI

27 

Dean HT: Endemic fluorosis and its relation to dental caries. 1938. Public Health Rep. 121(Suppl 1): 213–219; discussion 212. 2006.PubMed/NCBI

28 

Drozdzowska B, Pluskiewicz W and Tarnawska B: Panoramic-based mandibular indices in relation to mandibular bone mineral density and skeletal status assessed by dual energy X-ray absorptiometry and quantitative ultrasound. Dentomaxillofac Radiol. 31:361–367. 2002. View Article : Google Scholar : PubMed/NCBI

29 

Nordahl J, Andersson G and Reinholt FP: Chondroclasts and osteoclasts in bones of young rats: Comparison of ultrastructural and functional features. Calcif Tissue Int. 63:401–408. 1998. View Article : Google Scholar : PubMed/NCBI

30 

Nordahl J, Hollberg K, Mengarelli-Widholm S, Andersson G and Reinholt FP: Morphological and functional features of clasts in low phosphate, vitamin D-deficiency rickets. Calcif Tissue Int. 67:400–407. 2000. View Article : Google Scholar

31 

Chambers TJ: Regulation of the differentiation and function of osteoclasts. J Pathol. 192:4–13. 2000. View Article : Google Scholar : PubMed/NCBI

32 

Chen JQ, Heldman MR, Herrmann MA, Kedei N, Woo W, Blumberg PM and Goldsmith PK: Absolute quantitation of endogenous proteins with precision and accuracy using a capillary western system. Anal Biochem. 442:97–103. 2013. View Article : Google Scholar : PubMed/NCBI

33 

Dragomir A and Roomans GM: Increased chloride efflux in colchicine-resistant airway epithelial cell lines. Biochem Pharmacol. 68:253–261. 2004. View Article : Google Scholar : PubMed/NCBI

34 

Chen S, Wan XL and Sears M: pICln can regulate swelling-induced Cl− currents in either layer of rabbit ciliary epithelium. Biochem Biophys Res Commun. 246:59–63. 1998. View Article : Google Scholar : PubMed/NCBI

35 

Yan D, Gurumurthy A, Wright M, Pfeiler TW, Loboa EG and Everett ET: Genetic background influences fluoride's effects on osteoclastogenesis. Bone. 41:1036–1044. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Linkhart TA, Linkhart SG, Kodama Y, Farley JR, Dimai HP, Wright KR, Wergedal JE, Sheng M, Beamer WG, Donahue LR, et al: Osteoclast formation in bone marrow cultures from two inbred strains of mice with different bone densities. J Bone Miner Res. 14:39–46. 1999. View Article : Google Scholar : PubMed/NCBI

37 

Judex S, Garman R, Squire M, Donahue LR and Rubin C: Genetically based influences on the site-specific regulation of trabecular and cortical bone morphology. J Bone Miner Res. 19:600–606. 2004. View Article : Google Scholar : PubMed/NCBI

38 

Turner CH, Hsieh YF, Müller R, Bouxsein ML, Baylink DJ, Rosen CJ, Grynpas MD, Donahue LR and Beamer WG: Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res. 15:1126–1131. 2000. View Article : Google Scholar : PubMed/NCBI

39 

Turner CH, Hsieh YF, Müller R, Bouxsein ML, Rosen CJ, McCrann ME, Donahue LR and Beamer WG: Variation in bone biomechanical properties, microstructure, and density in BXH recombinant inbred mice. J Bone Miner Res. 16:206–213. 2001. View Article : Google Scholar : PubMed/NCBI

40 

Szewczyk KA, Fuller K and Chambers TJ: Distinctive subdomains in the resorbing surface of osteoclasts. PLoS One. 8:e602852013. View Article : Google Scholar : PubMed/NCBI

41 

Wu H1, Xu G and Li YP: Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J Bone Miner Res. 24:871–885. 2009. View Article : Google Scholar :

42 

Väänänen K: Mechanism of osteoclast mediated bone resorption - rationale for the design of new therapeutics. Adv Drug Deliv Rev. 57:959–971. 2005. View Article : Google Scholar

43 

Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, De Rossi G, Dionisi-Vici C, Pinto RM, Francalanci P, Boldrini R, et al: Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol. 162:57–68. 2003. View Article : Google Scholar : PubMed/NCBI

44 

de Vernejoul MC and Bénichou O: Human osteopetrosis and other sclerosing disorders: Recent genetic developments. Calcif Tissue Int. 69:1–6. 2001. View Article : Google Scholar : PubMed/NCBI

45 

Pei J, Li B, Gao Y, Wei Y, Zhou L, Yao H, Wang J and Sun D: Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression. Environ Toxicol. 29:588–595. 2014. View Article : Google Scholar

46 

Teitelbaum SL: Bone resorption by osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI

47 

Teitelbaum SL and Ross FP: Genetic regulation of osteoclast development and function. Nat Rev Genet. 4:638–649. 2003. View Article : Google Scholar : PubMed/NCBI

48 

Neutzsky-Wulff AV, Sims NA, Supanchart C, Kornak U, Felsenberg D, Poulton IJ, Martin TJ, Karsdal MA and Henriksen K: Severe developmental bone phenotype in ClC-7 deficient mice. Dev Biol. 344:1001–1010. 2010. View Article : Google Scholar : PubMed/NCBI

49 

Plans V, Rickheit G and Jentsch TJ: Physiological roles of CLC Cl(−)/H (+) exchangers in renal proximal tubules. Pflugers Arch. 458:23–37. 2009. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li BY, Gao YH, Pei JR, Yang YM, Zhang W and Sun DJ: ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis. Int J Mol Med 39: 1155-1163, 2017.
APA
Li, B., Gao, Y., Pei, J., Yang, Y., Zhang, W., & Sun, D. (2017). ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis. International Journal of Molecular Medicine, 39, 1155-1163. https://doi.org/10.3892/ijmm.2017.2933
MLA
Li, B., Gao, Y., Pei, J., Yang, Y., Zhang, W., Sun, D."ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis". International Journal of Molecular Medicine 39.5 (2017): 1155-1163.
Chicago
Li, B., Gao, Y., Pei, J., Yang, Y., Zhang, W., Sun, D."ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis". International Journal of Molecular Medicine 39, no. 5 (2017): 1155-1163. https://doi.org/10.3892/ijmm.2017.2933
Copy and paste a formatted citation
x
Spandidos Publications style
Li BY, Gao YH, Pei JR, Yang YM, Zhang W and Sun DJ: ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis. Int J Mol Med 39: 1155-1163, 2017.
APA
Li, B., Gao, Y., Pei, J., Yang, Y., Zhang, W., & Sun, D. (2017). ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis. International Journal of Molecular Medicine, 39, 1155-1163. https://doi.org/10.3892/ijmm.2017.2933
MLA
Li, B., Gao, Y., Pei, J., Yang, Y., Zhang, W., Sun, D."ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis". International Journal of Molecular Medicine 39.5 (2017): 1155-1163.
Chicago
Li, B., Gao, Y., Pei, J., Yang, Y., Zhang, W., Sun, D."ClC-7/Ostm1 contribute to the ability of tea polyphenols to maintain bone homeostasis in C57BL/6 mice, protecting against fluorosis". International Journal of Molecular Medicine 39, no. 5 (2017): 1155-1163. https://doi.org/10.3892/ijmm.2017.2933
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team